This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Jason Hall during the Emerging Treatment for Diverticulitis: Making Sense of the Evidence Amidst the Controversy on April 13 2018
Keyword(s): abdominal, abscess, acute diverticulitis, antibiotic regimen, antibiotics, AVOD trial, colectomy, complicated diverticulitis, CT scan, DIABOLO trial, discharge, diverticular disease, diverticulosis, diverticulum, emerging treatment, epigenetics, Europe, fever, Hinchey 1a, Hinchey 1b, hospital admissions, incidence, inflammatory response, inpatient, intavenous fluids, IVF, length of stay, LOS, management, microbiome, multicenter, normal diet, observation, observation group, outpatient, pain score, pathogenesis, pericolonic inflammation, primary outcome, prospective cohort study, randomized trial, readmission, recurrent diverticulitis, retrospective cohort study, secondary endpoints, selection bias, SUDD, symptomatic unclimpated diverticular disease, temperature, time to recovery, Tylenol, Type 2 error
Medical managment of antibiotics–15 sec Scand J Gastroenterol 2016
Are antibiotis necessary?–1:14 Colorectal Dis 2012
AVOD trial–2:40
DIABOLO trial–4:14 Br J Surg 2017
Outpatients–7:10 Int J Colorectal Dis 2015
Short course ABX therapy–7:56 Int J Colorectal Dis 2010